Cargando…
Challenges and Adaptation of a European Influenza Vaccine Effectiveness Study Platform in Response to the COVID-19 Emergence: Experience from the DRIVE Project
The Development of Robust and Innovative Vaccine Effectiveness (DRIVE) project is a public–private partnership aiming to build capacity in Europe for yearly estimation of brand-specific influenza vaccine effectiveness (IVE). DRIVE is a five-year project funded by IMI (Innovative Medicines Initiative...
Autores principales: | Carmona, Antonio, Muñoz-Quiles, Cintia, Stuurman, Anke, Descamps, Alexandre, Mira-Iglesias, Ainara, Torcel-Pagnon, Laurence, Díez-Domingo, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908420/ https://www.ncbi.nlm.nih.gov/pubmed/33504081 http://dx.doi.org/10.3390/ijerph18031058 |
Ejemplares similares
-
Investigating confounding in network‐based test‐negative design influenza vaccine effectiveness studies—Experience from the DRIVE project
por: Stuurman, Anke L., et al.
Publicado: (2022) -
Brand-specific estimates of influenza vaccine effectiveness for the 2021–2022 season in Europe: results from the DRIVE multi-stakeholder study platform
por: Stuurman, Anke L., et al.
Publicado: (2023) -
Predictors of influenza severity among hospitalized adults with laboratory confirmed influenza: Analysis of nine influenza seasons from the Valencia region, Spain
por: Derqui, Nieves, et al.
Publicado: (2022) -
Factors driving choices between types and brands of influenza vaccines in general practice in Austria, Italy, Spain and the UK
por: Stuurman, Anke L., et al.
Publicado: (2021) -
Impact of Underlying Conditions on Zoster-Related Pain and on Quality of Life Following Zoster
por: Torcel-Pagnon, Laurence, et al.
Publicado: (2017)